To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RHBDD3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
219 supporting clones for gene RHBDD3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA879479 Prostate .a 1 to 507 2 to 507   tiling clone, to resequence, capped   506/506
(100 %)
3 diff
(99.5 %id)
DA519960 brain .a 107 to 520 2 to 416   tiling clone, capped   415/415
(100 %)
1 diff
(99.8 %id)
DB330276 Prostate .a 1271 to 1815 545 to 1   tiling clone, to resequence,   545/545
(100 %)
0 diff
(100 %id)
DB103159 thymus .b 1 to 555 2 to 556   tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
AL120483 amygdala .b 40 to 538 1 to 499       499/500
(99 %)
1 diff
(99.8 %id)
DA736618   .b 109 to 834 2 to 725   capped   724/724
(100 %)
2 diff
(99.8 %id)
BQ437946 melanotic melanoma, skin .b 164 to 1034 1 to 883       883/895
(98 %)
21 diff
(97.7 %id)
CN419034 embryonic stem cells, cell lines H1, H7, andH9 .b 196 to 923 34 to 756       723/756
(95 %)
0 diff
(100 %id)
DA049776   .b 279 to 817 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
BQ053724 blood, natural killer cells, cell line .b 362 to 1231 1 to 882   tiling clone,   882/981
(89 %)
30 diff
(97.0 %id)
CF140448 CNCAP(3)T-225 cell line, Prostate .b 430 to 819 7 to 398       392/398
(98 %)
8 diff
(98.0 %id)
TI_154170927   .b 430 to 950 93 to 619       527/1031
(51 %)
33 diff
(96.8 %id)
DA371240 thalamus .b 503 to 834 199 to 530   capped   332/529
(62 %)
0 diff
(100 %id)
BG999543 head_normal .b 582 to 688 119 to 12       108/119
(90 %)
0 diff
(100 %id)
BQ893569 dorsal root ganglia .b 595 to 1426 1 to 839       839/924
(90 %)
23 diff
(97.6 %id)
CD243732 testis .b 601 to 1377 1 to 783       783/861
(90 %)
6 diff
(99.4 %id)
BM700526 eye, lens .b 626 to 1225 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
BM726138 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 626 to 1170 1 to 545       545/545
(100 %)
3 diff
(99.5 %id)
CN419033 embryonic stem cells, cell lines H1, H7, andH9 .b 645 to 1287 8 to 650       643/650
(98 %)
0 diff
(100 %id)
R61576 whole brain .b 664 to 1036 1 to 375       375/423
(88 %)
6 diff
(98.6 %id)
BF984066 duodenal adenocarcinoma, cell line, small intestine .b 708 to 1401 1 to 688       688/779
(88 %)
16 diff
(98.0 %id)
BQ670744 epidermoid carcinoma, cell line, salivary gland .b 765 to 1349 1 to 587       587/1001
(58 %)
13 diff
(98.8 %id)
R86650 brain .b 790 to 1138 1 to 352       352/355
(99 %)
8 diff
(97.8 %id)
BQ067021 brain .b 799 to 1345 1 to 551       551/1247
(44 %)
39 diff
(96.9 %id)
H23342 whole brain .b 801 to 1171 378 to 3     Submitted on the opposite strand 376/380
(98 %)
0 diff
(100 %id)
CV575778 cornea, eye .b 834 to 1448 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BM689742 eye, Retina Foveal and Macular .b 862 to 1338 7 to 483       477/483
(98 %)
0 diff
(100 %id)
BG034338 breast, mammary adenocarcinoma, cell line .b 891 to 1534 1 to 653       653/995
(65 %)
44 diff
(95.6 %id)
BQ636584 eye, retina .b 909 to 1409 16 to 516       501/516
(97 %)
0 diff
(100 %id)
BQ918247 sciatic nerve .b 967 to 1811 1 to 857       853/858
(99 %)
14 diff
(98.4 %id)
DN601583 human embryonic stem cells .b 1015 to 1753 1 to 739   tiling clone,   739/739
(100 %)
0 diff
(100 %id)
BQ636566 eye, retina .b 1068 to 1226 1 to 159       159/159
(100 %)
0 diff
(100 %id)
BM682569 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1734 to 2348 633 to 19   tiling clone, AAA   615/615
(100 %)
0 diff
(100 %id)
DB342616 thymus .b 1786 to 2355 570 to 1       570/570
(100 %)
1 diff
(99.9 %id)
DB296220   .b 1804 to 2348 545 to 1       545/545
(100 %)
0 diff
(100 %id)
DB369138   .b 1837 to 2347 509 to 1       509/545
(93 %)
22 diff
(96.0 %id)
BM661710 eye, Retina Foveal and Macular .b 1852 to 2365 533 to 20   AAA   514/514
(100 %)
0 diff
(100 %id)
DB561095 hypothalamus .b 1979 to 2348 1 to 367     Submitted on the opposite strand 367/367
(100 %)
10 diff
(97.3 %id)
AI222511 Kidney .b 1982 to 2348 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AI832652 colon .b 1984 to 2348 365 to 1       365/366
(99 %)
4 diff
(99.0 %id)
BF063637 colon, colon tumor, RER+ .b 1989 to 2345 360 to 4       357/360
(99 %)
0 diff
(100 %id)
AA769211 germinal center B cell .b 1991 to 2348 375 to 19   AAA   357/357
(100 %)
2 diff
(99.5 %id)
R86829 brain .b 1996 to 2329 336 to 1       336/336
(100 %)
4 diff
(98.9 %id)
BQ218134 epithelioid carcinoma, Pancreas .b 2004 to 2348 1 to 345   AAA   345/345
(100 %)
1 diff
(99.8 %id)
TI_158435495   .b 2015 to 2348 423 to 84   AAA   340/1060
(32 %)
9 diff
(99.2 %id)
AW135655   .b 2016 to 2369 372 to 19   AAA   354/354
(100 %)
1 diff
(99.8 %id)
H51131 brain .b 2029 to 2321 294 to 1       294/294
(100 %)
3 diff
(99.0 %id)
F25808 pectoral muscle (after mastectomy) .b 2029 to 2344 1 to 316       316/316
(100 %)
0 diff
(100 %id)
R61520 whole brain .b 2030 to 2366 343 to 9   tiling clone,   335/343
(97 %)
0 diff
(100 %id)
AI468304 Prostate .b 2042 to 2348 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
AA827130 germinal center B cell .b 2045 to 2348 323 to 19   AAA   305/305
(100 %)
1 diff
(99.7 %id)
AI701217 adenocarcinoma, Pancreas .b 2053 to 2348 296 to 1       296/296
(100 %)
9 diff
(97.0 %id)
BM987788 mixed .b 2067 to 2347 299 to 19   AAA   281/281
(100 %)
1 diff
(99.7 %id)
R06729 liver and spleen .b 2068 to 2347 278 to 1       278/278
(100 %)
13 diff
(95.4 %id)
AA826693 invasive tumor (cell line), Prostate .b 2076 to 2367 309 to 20   AAA   290/290
(100 %)
3 diff
(99.0 %id)
AW087238 colon, moderately differentiated adenocarcinoma .b 2106 to 2348 243 to 1       243/243
(100 %)
0 diff
(100 %id)
BU753898 placenta .b 2106 to 2348 260 to 18   AAA   243/243
(100 %)
0 diff
(100 %id)
AI202222 Prostate .b 2112 to 2350 243 to 5       239/243
(98 %)
0 diff
(100 %id)
BU536072 mixed (pool of 40 RNAs) .b 2158 to 2348 1 to 191       191/226
(84 %)
2 diff
(99.2 %id)
AA838528 epithelium (cell line), Prostate .b 2160 to 2350 196 to 3       194/196
(98 %)
0 diff
(100 %id)
AI687772 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 2172 to 2348 177 to 1       177/177
(100 %)
0 diff
(100 %id)
EC451062 Prostate .b 2200 to 2303 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
BQ777143 Pancreas, Purified pancreatic islet .b 2203 to 2350 1 to 148   fully sequenced,   148/148
(100 %)
2 diff
(98.7 %id)
BM311243 Pancreas, Purified pancreatic islet .b 2205 to 2350 9 to 154       146/167
(87 %)
1 diff
(99.5 %id)
CK821674 Pancreas, Purified pancreatic islet .b 2205 to 2348 158 to 15   AAA Submitted on the opposite strand 144/155
(92 %)
0 diff
(100 %id)
N57993 liver and spleen .b 2217 to 2348 134 to 3       132/141
(93 %)
0 diff
(100 %id)
CK821673 Pancreas, Purified pancreatic islet .b 2243 to 2348 1 to 106     Submitted on the opposite strand 106/106
(100 %)
0 diff
(100 %id)
BQ778252 Pancreas, Purified pancreatic islet .b 2250 to 2350 101 to 1   fully sequenced,   101/101
(100 %)
0 diff
(100 %id)
BM311832 Pancreas, Purified pancreatic islet .b 2268 to 2350 83 to 1       83/83
(100 %)
0 diff
(100 %id)
DB490745 hypothalamus .c 1 to 426 1 to 425   tiling clone,   425/425
(100 %)
13 diff
(97.0 %id)
CR594348 Placenta Cot 25-normalized .c 2 to 1759 1 to 1758 exact     1758/1758
(100 %)
0 diff
(100 %id)
BX324390 Neuroblastoma Cot 25-normalized .c 3 to 951 1 to 935       935/939
(99 %)
20 diff
(97.9 %id)
BX324391 Neuroblastoma Cot 25-normalized .c 3 to 720 1 to 715       715/715
(100 %)
6 diff
(99.2 %id)
BX379337 Placenta Cot 25-normalized .c 3 to 837 1 to 830   fully sequenced,   830/830
(100 %)
7 diff
(99.2 %id)
CR606788 Placenta Cot 25-normalized .c 9 to 1745 1 to 1737 exact     1737/1737
(100 %)
0 diff
(100 %id)
BX377758 Placenta Cot 25-normalized .c 9 to 951 1 to 929       929/933
(99 %)
20 diff
(97.9 %id)
BQ717815 dorsal root ganglia .c 16 to 530 1 to 515       515/1048
(49 %)
6 diff
(99.5 %id)
CN308896 embryonic stem cells, DMSO-treated H9 cellline .c 21 to 511 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BQ067893 brain .c 25 to 572 1 to 548       548/1100
(49 %)
4 diff
(99.7 %id)
BE614065 leiomyosarcoma, uterus .c 27 to 708 1 to 676       676/928
(72 %)
12 diff
(98.8 %id)
CB988785 Human Placenta, placenta .c 28 to 745 27 to 753       727/793
(91 %)
17 diff
(97.9 %id)
TI_57199356   .c 28 to 927 25 to 913       889/926
(96 %)
17 diff
(98.2 %id)
BM926242 brain .c 30 to 759 19 to 755       737/1072
(68 %)
19 diff
(98.3 %id)
CR593733 T cells (Jurkat cell line) .c 32 to 1770 1 to 1739 exact tiling clone,   1739/1739
(100 %)
0 diff
(100 %id)
BX411077 T cells (Jurkat cell line) .c 32 to 958 1 to 923       923/958
(96 %)
11 diff
(98.9 %id)
BX411078 T cells (Jurkat cell line) .c 32 to 574 1 to 543       543/824
(65 %)
54 diff
(93.5 %id)
BX422006 T cells (Jurkat cell line) .c 32 to 717 1 to 691       691/691
(100 %)
20 diff
(97.2 %id)
BM557742 duodenal adenocarcinoma, cell line, small intestine .c 32 to 548 1 to 521       521/1186
(43 %)
23 diff
(98.1 %id)
BI819501 pooled brain, lung, testis .c 33 to 927 1 to 884       884/897
(98 %)
17 diff
(98.2 %id)
BU856396 ovary, teratocarcinoma, cell line .c 40 to 617 25 to 607       583/865
(67 %)
8 diff
(99.1 %id)
CN308893 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 52 to 207 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
AL050346   .c 55 to 1792 1 to 1738 exact     1738/1738
(100 %)
0 diff
(100 %id)
NM_012265.1   .c 55 to 1792 1 to 1738 exact RefSeq,   1738/1738
(100 %)
0 diff
(100 %id)
CB992905 placenta, pre-eclamptic placenta .c 59 to 736 28 to 712       685/820
(83 %)
18 diff
(97.9 %id)
BM768893 stomach .c 59 to 744 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
BM843361 stomach .c 59 to 651 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BI826134 brain, medulla .c 69 to 602 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
TI_57173994   .c 69 to 602 28 to 561       534/561
(95 %)
0 diff
(100 %id)
BG764458 melanotic melanoma, high MDR (cell line), skin .c 74 to 956 1 to 882       882/896
(98 %)
38 diff
(95.8 %id)
AA362677   .c 76 to 339 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
W93747 heart .c 81 to 365 19 to 303       285/303
(94 %)
0 diff
(100 %id)
CX754171 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 87 to 525 1 to 439     Submitted on the opposite strand 439/441
(99 %)
1 diff
(99.8 %id)
H23229 whole brain .c 104 to 471 1 to 373     Submitted on the opposite strand 373/373
(100 %)
11 diff
(97.1 %id)
BF983213 duodenal adenocarcinoma, cell line, small intestine .c 120 to 826 1 to 702       702/705
(99 %)
11 diff
(98.5 %id)
BU193395 eye, retinoblastoma .c 128 to 741 1 to 615       615/930
(66 %)
28 diff
(97.0 %id)
CN308892 embryonic stem cells, cell lines H1, H7, andH9 .c 173 to 511 1 to 339       339/339
(100 %)
0 diff
(100 %id)
BM827228 Ascites, stomach .c 188 to 834 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
AA290815 ovarian tumor, ovary .c 191 to 524 1 to 335       335/335
(100 %)
6 diff
(98.3 %id)
CX758540 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 237 to 954 20 to 733     Submitted on the opposite strand 714/786
(90 %)
26 diff
(96.7 %id)
AA195690 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 243 to 530 1 to 286       286/297
(96 %)
5 diff
(98.4 %id)
N31013 melanocyte .c 244 to 657 1 to 411       411/411
(100 %)
10 diff
(97.6 %id)
BX347602 Placenta Cot 25-normalized .c 263 to 951 692 to 5       688/793
(86 %)
10 diff
(98.8 %id)
BM694310 eye, RPE and Choroid .c 269 to 747 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
CR456411   .c 349 to 1687 1 to 1339 exact     1339/1339
(100 %)
0 diff
(100 %id)
BQ430431 epithelioid carcinoma, Pancreas .c 370 to 1022 1 to 654       654/888
(73 %)
18 diff
(98.0 %id)
BG035110 adenocarcinoma, cell line, Liver .c 371 to 1117 1 to 750       750/1124
(66 %)
13 diff
(98.9 %id)
CX758887 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 378 to 1091 1 to 714     Submitted on the opposite strand 714/716
(99 %)
1 diff
(99.9 %id)
BC002705 Brain, neuroblastoma .c 404 to 1773 1 to 1370 exact available from MGC, AAA   1370/1370
(100 %)
0 diff
(100 %id)
BC018872 Brain, neuroblastoma .c 404 to 1773 1 to 1370   available from MGC, AAA   1370/1370
(100 %)
0 diff
(100 %id)
BE382897 brain, neuroblastoma .c 423 to 1112 1 to 687       687/745
(92 %)
14 diff
(98.2 %id)
CR457382   .c 427 to 1586 1 to 1160       1160/1161
(99 %)
3 diff
(99.8 %id)
EL733243 mixed .c 427 to 1008 1 to 578       578/580
(99 %)
5 diff
(99.2 %id)
CU013259 Synthetic constructs .c 427 to 1584 20 to 1177       1158/1192
(97 %)
1 diff
(100.0 %id)
CU012971 Synthetic constructs .c 427 to 1589 20 to 1182 exact     1163/1195
(97 %)
1 diff
(100.0 %id)
CA487212   .c 504 to 1122 1 to 620       620/913
(67 %)
7 diff
(99.3 %id)
BX407303 T cells (Jurkat cell line) .c 524 to 1364 1 to 834       834/989
(84 %)
29 diff
(97.1 %id)
BX282185 pooled lung and spleen .c 608 to 1121 29 to 542       514/542
(94 %)
0 diff
(100 %id)
BM925171 pooled lung and spleen .c 608 to 1483 1 to 874       874/1065
(82 %)
11 diff
(99.0 %id)
BU557758 adenocarcinoma, cell line, breast .c 696 to 1489 12 to 808       797/985
(80 %)
8 diff
(99.2 %id)
BX411076 T cells (Jurkat cell line) .c 707 to 1737 1035 to 5       1031/1035
(99 %)
46 diff
(95.6 %id)
BU502775 carcinoma, cell line, Prostate .c 766 to 1592 29 to 866       838/988
(84 %)
25 diff
(97.5 %id)
BM048213 carcinoma, cell line, Prostate .c 769 to 1575 1 to 836       833/1005
(82 %)
41 diff
(96.0 %id)
BU543922 carcinoma, cell line, Prostate .c 770 to 1609 1 to 848       848/876
(96 %)
12 diff
(98.7 %id)
BX377757 Placenta Cot 25-normalized .c 783 to 1715 951 to 28       924/975
(94 %)
17 diff
(98.3 %id)
BX357998 Placenta Cot 25-normalized .c 807 to 1759 956 to 1   fully sequenced,   956/956
(100 %)
26 diff
(97.3 %id)
BM142072 Islets of Langerhans, Pancreas .c 853 to 1325 1 to 473   fully sequenced,   473/473
(100 %)
0 diff
(100 %id)
BX324388 Neuroblastoma Cot 25-normalized .c 962 to 1717 761 to 1       761/761
(100 %)
9 diff
(98.9 %id)
TI_154126353   .c 969 to 1773 857 to 63   AAA   795/966
(82 %)
20 diff
(98.0 %id)
TI_149297631   .c 981 to 1773 869 to 82   AAA   788/957
(82 %)
13 diff
(98.7 %id)
TI_149302898   .c 984 to 1773 853 to 64   AAA   790/958
(82 %)
5 diff
(99.5 %id)
BX324389 Neuroblastoma Cot 25-normalized .c 999 to 1741 743 to 1       743/743
(100 %)
0 diff
(100 %id)
TI_159678538   .c 1021 to 1773 869 to 127   AAA   743/929
(79 %)
36 diff
(96.2 %id)
BM981011 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1078 to 1773 714 to 19   AAA   696/696
(100 %)
0 diff
(100 %id)
BM982659 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1081 to 1773 711 to 19   AAA   693/693
(100 %)
2 diff
(99.8 %id)
BU740341 eye, lens .c 1081 to 1773 713 to 19   AAA   695/695
(100 %)
2 diff
(99.8 %id)
BI767265 pooled lung and spleen .c 1136 to 1773 1 to 638   AAA   638/638
(100 %)
1 diff
(99.9 %id)
TI_57181674   .c 1136 to 1773 36 to 673   AAA   638/673
(94 %)
1 diff
(99.9 %id)
CN308891 embryonic stem cells, DMSO-treated H9 cellline .c 1137 to 1571 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
BU730430 eye, RPE and Choroid .c 1158 to 1773 634 to 19   AAA   616/616
(100 %)
1 diff
(99.9 %id)
CA417106 Chondrosarcoma Cell line .c 1158 to 1773 633 to 19   AAA   615/615
(100 %)
2 diff
(99.7 %id)
CA424530 cell lines, Chondrosarcoma .c 1164 to 1773 629 to 19   AAA   611/611
(100 %)
2 diff
(99.7 %id)
BM971913 lung .c 1165 to 1773 627 to 19   AAA   609/609
(100 %)
0 diff
(100 %id)
BM666280 eye, fetal eyes .c 1171 to 1773 621 to 19   AAA   603/603
(100 %)
1 diff
(99.9 %id)
CA416510 Chondrosarcoma Cell line .c 1183 to 1773 609 to 19   AAA   591/591
(100 %)
3 diff
(99.5 %id)
BF059523 pooled germ cell tumors .c 1188 to 1795 608 to 5       604/608
(99 %)
28 diff
(95.4 %id)
AA411442 ovarian tumor, ovary .c 1203 to 1774 574 to 1       574/577
(99 %)
12 diff
(98.0 %id)
BU738111 eye, lens .c 1205 to 1773 588 to 19   AAA   570/570
(100 %)
1 diff
(99.9 %id)
BU620681 cell lines, Chondrosarcoma .c 1207 to 1773 587 to 19   AAA   569/569
(100 %)
4 diff
(99.3 %id)
W93696 heart .c 1237 to 1775 545 to 4       542/546
(99 %)
19 diff
(96.6 %id)
AI831232 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1266 to 1775 511 to 1       511/511
(100 %)
5 diff
(99.1 %id)
BU622875 cell lines, Enchondroma .c 1274 to 1794 539 to 19   tiling clone, AAA   521/521
(100 %)
1 diff
(99.9 %id)
AI831093 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1277 to 1775 501 to 3       499/501
(99 %)
1 diff
(99.9 %id)
AI761275 2 pooled tumors (clear cell type), Kidney .c 1279 to 1775 498 to 2       497/498
(99 %)
0 diff
(100 %id)
BE677694 dorsal root ganglia .c 1279 to 1773 495 to 1       495/495
(100 %)
0 diff
(100 %id)
BE645104 pooled .c 1279 to 1772 494 to 1       494/494
(100 %)
0 diff
(100 %id)
BU631935 cell lines, Chondrosarcoma .c 1283 to 1780 514 to 19   AAA   496/496
(100 %)
2 diff
(99.6 %id)
BM141791 Islets of Langerhans, Pancreas .c 1295 to 1775 484 to 4   fully sequenced,   481/484
(99 %)
0 diff
(100 %id)
AI675187 anaplastic oligodendroglioma, brain .c 1297 to 1773 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI671935 Kidney .c 1297 to 1775 483 to 5       479/483
(99 %)
0 diff
(100 %id)
AI760240 pooled .c 1297 to 1775 482 to 3       480/482
(99 %)
0 diff
(100 %id)
AI963599 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1297 to 1775 481 to 3       479/481
(99 %)
1 diff
(99.8 %id)
AI421006 Prostate .c 1300 to 1775 481 to 6       476/481
(98 %)
0 diff
(100 %id)
BM987630 mixed .c 1301 to 1773 491 to 19   AAA   473/473
(100 %)
0 diff
(100 %id)
BE645796 Prostate .c 1303 to 1775 477 to 5       473/477
(99 %)
0 diff
(100 %id)
CF529583 placenta .c 1303 to 1773 489 to 19   AAA   471/476
(98 %)
0 diff
(100 %id)
AA603792 breast .c 1304 to 1794 489 to 1       489/489
(100 %)
2 diff
(99.6 %id)
AI804496 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1311 to 1773 486 to 24   AAA   463/463
(100 %)
1 diff
(99.8 %id)
AI253038 Kidney .c 1312 to 1773 473 to 12   AAA   462/462
(100 %)
3 diff
(99.4 %id)
AW206094   .c 1330 to 1773 461 to 18   AAA   444/447
(99 %)
4 diff
(99.2 %id)
TI_153990072   .c 1330 to 1773 534 to 91   AAA   444/656
(67 %)
4 diff
(99.4 %id)
AW770243 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1331 to 1773 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI439672 B-cell, chronic lymphotic leukemia .c 1350 to 1775 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AI933358 anaplastic oligodendroglioma, brain .c 1353 to 1773 419 to 1       419/419
(100 %)
5 diff
(98.9 %id)
AI635537 pooled germ cell tumors .c 1363 to 1773 429 to 19   AAA   411/422
(97 %)
2 diff
(99.6 %id)
CF529639 placenta .c 1363 to 1773 429 to 19   AAA   411/411
(100 %)
0 diff
(100 %id)
BF510387   .c 1375 to 1773 416 to 18   AAA   399/399
(100 %)
2 diff
(99.5 %id)
AA284627 ovarian tumor, ovary .c 1438 to 1774 337 to 1       337/337
(100 %)
0 diff
(100 %id)
BG761662 melanotic melanoma, high MDR (cell line), skin .d-u 1 to 606 1 to 606   tiling clone,   606/606
(100 %)
1 diff
(99.9 %id)
BF345502 anaplastic oligodendroglioma with 1p/19qloss, brain .d-u 71 to 842 1 to 772       772/824
(93 %)
15 diff
(98.2 %id)
AW572508 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d-u 533 to 893 361 to 1   tiling clone,   361/361
(100 %)
0 diff
(100 %id)
AA018220 eye, retina .d-u 625 to 1027 418 to 3   tiling clone,   416/418
(99 %)
0 diff
(100 %id)
BF762173 colon_est .d-u 727 to 892 167 to 2     Submitted on the opposite strand 166/167
(99 %)
0 diff
(100 %id)
TI_57180264   .e 1 to 705 24 to 723   tiling clone,   700/723
(96 %)
10 diff
(98.7 %id)
BI772204 pooled lung and spleen .e 6 to 705 1 to 695   tiling clone,   695/695
(100 %)
13 diff
(98.2 %id)
BM564366 duodenal adenocarcinoma, cell line, small intestine .f 1 to 708 1 to 711   tiling clone,   711/1052
(67 %)
9 diff
(99.2 %id)
BU856227 ovary, teratocarcinoma, cell line .f 47 to 911 1 to 872 A130G G131W E132G H134T R135P ... tiling clone,   872/873
(99 %)
12 diff
(98.7 %id)
TI_149286297   .g 1 to 822 907 to 84 A2V tiling clone, AAA   824/826
(99 %)
22 diff
(97.4 %id)
TI_57234595   .h 1 to 752 30 to 786 E42G L43A L44V L45A D46G ... tiling clone,   757/789
(95 %)
12 diff
(98.5 %id)
BI908673 leukocyte .h 2 to 752 1 to 756 E42G L43A L44V L45A D46G ... tiling clone,   756/759
(99 %)
17 diff
(97.8 %id)
BG774440 choriocarcinoma, placenta .i-u 1 to 831 1 to 828   tiling clone,   828/830
(99 %)
23 diff
(97.3 %id)
CB049484 Prostate .i-u 181 to 826 14 to 659   tiling clone,   646/659
(98 %)
0 diff
(100 %id)
AA321619 lymphoid .i-u 194 to 522 1 to 331       331/332
(99 %)
5 diff
(98.5 %id)
BG028660 Bone, osteosarcoma, cell line .i-u 412 to 1083 1 to 672   tiling clone,   672/672
(100 %)
5 diff
(99.3 %id)
BG676409 skin, squamous cell carcinoma .i-u 1018 to 1402 1 to 383   tiling clone,   383/730
(52 %)
8 diff
(99.0 %id)
AI597877 Prostate .i-u 1261 to 1653 393 to 1       393/394
(99 %)
0 diff
(100 %id)
CB049483 Prostate .i-u 1268 to 1653 409 to 24   AAA   386/386
(100 %)
0 diff
(100 %id)
BM543850 ovary (pool of 3) .i-u 1268 to 1793 528 to 1   tiling clone, Submitted on the opposite strand 528/532
(99 %)
5 diff
(99.1 %id)
AI597885 Prostate .i-u 1277 to 1653 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AI862634 2 pooled tumors (clear cell type), Kidney .i-u 1278 to 1654 377 to 1       377/377
(100 %)
0 diff
(100 %id)
CR592918 T cells (Jurkat cell line) Cot10-normalized .j 1 to 1555 1 to 1555 exact tiling clone,   1555/1555
(100 %)
0 diff
(100 %id)
BX362368   .j 2 to 766 1 to 765       765/765
(100 %)
5 diff
(99.4 %id)
AA419008 ovarian tumor, ovary .j 19 to 378 1 to 359       359/359
(100 %)
11 diff
(97.0 %id)
BX347692   .j 192 to 876 718 to 29       690/884
(78 %)
21 diff
(97.7 %id)
BX362367   .j 739 to 1555 820 to 1 D41*     820/820
(100 %)
4 diff
(99.6 %id)
TI_154127409   .j 763 to 1585 890 to 79 A2* tiling clone, AAA   812/967
(83 %)
18 diff
(98.2 %id)
AA423827 ovarian tumor, ovary .j 1282 to 1585 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BI712923 Pancreas, Purified pancreatic islet .k 1 to 471 1 to 472   tiling clone, fully sequenced,   472/472
(100 %)
2 diff
(99.6 %id)
BM925334 brain .k 7 to 891 1 to 890 V31G A33G G34R P35X G36R ...     890/1016
(87 %)
50 diff
(95.1 %id)
CB960433 Human Placenta, placenta .k 8 to 774 21 to 799 W29G V31X A33G G34A P35G ...     779/802
(97 %)
21 diff
(97.4 %id)
CN308894 embryonic stem cells, cell lines H1, H7, andH9 .k 10 to 775 1 to 768 A33G G34R G36R L37P V38G ... tiling clone,   768/768
(100 %)
3 diff
(99.7 %id)
BM479555 embryonal carcinoma, cell line, testis .k 26 to 842 1 to 833 L30X V31G G32W A33G G34P ...     833/1098
(75 %)
26 diff
(97.7 %id)
CN308895 embryonic stem cells, cell lines H1, H7, andH9 .k 72 to 729 1 to 657 A33G G34R G36R L37P V38G ...     657/657
(100 %)
6 diff
(99.1 %id)
BG489409 large cell carcinoma, lung .k 228 to 859 1 to 620 H2M A3P R4G G5P H7W ...     620/621
(99 %)
23 diff
(96.3 %id)
BI791513 Pancreas, Purified pancreatic islet .k 441 to 946 506 to 1   tiling clone, fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
DA046081 bladder .k 444 to 1016 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ681574 melanotic melanoma, cell line, skin .k 642 to 1080 1 to 439   AAA   439/439
(100 %)
4 diff
(99.1 %id)
BU838849 melanotic melanoma, cell line, skin .k 647 to 1080 1 to 434   tiling clone, AAA   434/434
(100 %)
1 diff
(99.8 %id)
BE870212 adenocarcinoma, colon .l 1 to 410 1 to 407 P3A L26S A28P G29A L30W ... tiling clone,   407/407
(100 %)
4 diff
(99.1 %id)
AA018139 eye, retina Gene RHBDD3, variant not shown         This clone was ignored    
AA018187 eye, retina Gene RHBDD3, variant not shown         This clone was ignored    
AI352301   Gene RHBDD3, variant not shown         Suspected internal deletion, this clone was ignored    
AI978570 pooled germ cell tumors Gene RHBDD3, variant not shown         Suspected internal deletion, this clone was ignored    
AW005885 anaplastic oligodendroglioma, brain Gene RHBDD3, variant not shown         Suspected internal deletion, this clone was ignored    
BI461214 testis Gene RHBDD3, variant not shown         This clone was ignored    
CB989598 Human Placenta, placenta Gene RHBDD3, variant not shown         Suspected internal deletion, this clone was ignored    
TI_157605055   Gene RHBDD3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_157605065   Gene RHBDD3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h, .i-u, .j, .k, .l Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC